Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Orilissa for moderate to severe endometriosis pain

July 25, 2018

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent oxytocin receptor antagonists

July 24, 2018

let-7b as a novel biomarker of Graves' disease

July 24, 2018

INSERM and collaborators describe lactic acid bacteria compositions

July 23, 2018

BioMarin Pharmaceutical divulges CGT inhibitors

July 20, 2018

Beta cells make and secrete autoimmune peptides

July 19, 2018

Merck & Co. divulges FFA1 receptor agonists

July 18, 2018

Hot flashes are hypothalamic

July 18, 2018

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

July 17, 2018

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

July 17, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...